+ A
A -
Tribune News Network
Doha
On top of being listed among the UK’s most influential diabetes researchers, Professor of Medicine at Weill Cornell Medicine-Qatar (WCM-Q) Dr Rayaz Malik has also won the prestigious Camillo Golgi Prize this year.
Dr Malik was named UK’s second most influential clinical researcher in a list of “Leaders in Diabetes Complications” compiled by Expertscape, the world’s leading index of academic achievement and expertise in healthcare.
Expertscape ranks the performance of researchers impartially, using a series of objective metrics to judge the number and quality of research papers and the impact factor of the journal they have published in over the last ten years.
Although Dr Malik left the UK to join WCM-Q in 2014, he still holds an honorary professorship at his previous institution, the University of Manchester, hence his inclusion in the UK index.
Dr Malik also learnt that he had been awarded the prestigious Camillo Golgi Prize for outstanding contributions in the field of the histopathology, pathogenesis, prevention and treatment of the complications of diabetes mellitus.
The prize, which is awarded by the European Association for the Study of Diabetes (EASD) is named after renowned Italian biologist Camillo Golgi who won the Nobel Prize in 1906 for his studies on the nervous system and kidney physiology.
The prize recognizes investigators who have published research papers in internationally recognized scientific journals over the last five years which demonstrate continuing activity, originality and excellence in the field.
Dr Malik is the first recipient in the history of the Camillo Golgi Prize to be based outside Europe.
As the winner of the award, Dr Malik has been accorded the privilege of delivering the Camillo Golgi Prize lecture at the EASD Annual Meeting in September 2019 in Barcelona.
Dr Malik began his research into the pathophysiology and treatment of diabetic neuropathy whilst he was still a medical student in Aberdeen, Scotland.
Doha
On top of being listed among the UK’s most influential diabetes researchers, Professor of Medicine at Weill Cornell Medicine-Qatar (WCM-Q) Dr Rayaz Malik has also won the prestigious Camillo Golgi Prize this year.
Dr Malik was named UK’s second most influential clinical researcher in a list of “Leaders in Diabetes Complications” compiled by Expertscape, the world’s leading index of academic achievement and expertise in healthcare.
Expertscape ranks the performance of researchers impartially, using a series of objective metrics to judge the number and quality of research papers and the impact factor of the journal they have published in over the last ten years.
Although Dr Malik left the UK to join WCM-Q in 2014, he still holds an honorary professorship at his previous institution, the University of Manchester, hence his inclusion in the UK index.
Dr Malik also learnt that he had been awarded the prestigious Camillo Golgi Prize for outstanding contributions in the field of the histopathology, pathogenesis, prevention and treatment of the complications of diabetes mellitus.
The prize, which is awarded by the European Association for the Study of Diabetes (EASD) is named after renowned Italian biologist Camillo Golgi who won the Nobel Prize in 1906 for his studies on the nervous system and kidney physiology.
The prize recognizes investigators who have published research papers in internationally recognized scientific journals over the last five years which demonstrate continuing activity, originality and excellence in the field.
Dr Malik is the first recipient in the history of the Camillo Golgi Prize to be based outside Europe.
As the winner of the award, Dr Malik has been accorded the privilege of delivering the Camillo Golgi Prize lecture at the EASD Annual Meeting in September 2019 in Barcelona.
Dr Malik began his research into the pathophysiology and treatment of diabetic neuropathy whilst he was still a medical student in Aberdeen, Scotland.
